The worldwide market for clinical trial management is expected to reach more than $52 billion by 2030—and shows no signs of slowing. This rapid expansion has led to a growing need for clinical trial professionals able to shepherd potential therapies and cures through the testing necessary to ensure safety and effectiveness.
To meet this need, the USC Mann School of Pharmacy and Pharmaceutical Sciences has launched a Master of Science in Clinical Trial Management. The program’s courses, which start in the spring of 2025, are provided through the school’s pioneering Department of Regulatory and Quality Sciences.
“The demand for clinical trial professionals is substantial, driven by advances in science and technology that have led to the emergence of new molecules and potential therapies,” notes Eunjoo Pacifici, chair of the Department of Regulatory and Quality Sciences. “Our newly developed master’s program is designed to cultivate highly skilled clinical trial personnel for elevating research standards and facilitating therapeutic advancements.”
The curriculum includes courses in regulatory sciences along with a variety of electives. Students will further hone their skills in such specially designed classes as Clinical Trial Writing and Document Management and Clinical Trial Project Management.
“We prioritize practical application and hands-on expertise for effective learning and skill development,” Pacifici says. “The program aims to strengthen the competency of individuals who are aspiring to pursue a career in conducting clinical trials, as well as for seasoned clinical trial professionals looking to advance their careers.”
USC Mann’s MS in Clinical Trial Management will blend online classes with on-site labs and experiential learning opportunities. The program will also feature guest lectures from top professionals in the field and networking events with industry leaders.
The MS is designed with working professionals in mind. Students can register for evening and weekend classes and are free to pick their electives based on their specific interests and preferences. The virtual courses will enable students from around the world to earn their Clinical Trial Management MS from USC Mann.
“The Mann School has always been at the forefront of advancing excellence and opportunity in the pharmaceutical sciences,” says USC Mann Dean Vassilios Papadopoulos. “The new Master of Science in Clinical Trial Management is another example of our leadership, which not only stays ahead of the curve in preparing pharmacy experts but is also shaping the future of such vital areas as the regulatory sciences.”
For more information about USC Mann’s innovative Master’s Degree in Clinical Trial Management, contact regsci@usc.edu.